M. Schmidt et P. Grunsfelder, Urokinase-type plasminogen activator expression and proliferation stimulation in head and neck squamous cell carcinoma in vitro and in situ, ARCH OTOLAR, 127(6), 2001, pp. 679-682
Background: Stimulation of proliferative activity by urokinase-type plasmin
ogen activator (uPA) has been demonstrated in vitro for cultured primary an
d carcinoma cells.
Objective: To examine the effect of uPA stimulation on cultured squamous ce
ll carcinoma cell lines of the head and neck in vitro and to compare the re
sults with the situation in tumor tissue specimens.
Design: The uPA-mediated growth stimulation of 2 head and neck squamous cel
l carcinoma cell lines after suppression of endogenous uPA production was m
onitored by measuring H-3-thymidine uptake into cellular DNA. Alternatively
, applications of antibodies against the uPA-binding domain of the urokinas
e receptor were used to suppress autostimulation. To analyze the situation
in situ we performed Western blot and zymographic studies on tissue homogen
ates of 25 squamous cell carcinoma specimens. We tested the expression of p
roliferating cell nuclear antigen (PCNA), a marker for proliferative activi
ty, and uPA in tissue lysates and correlated uPA and PCNA expression by reg
ression analysis.
Results: High-molecular-weight urokinase had a proliferation stimulative ef
fect on both cell lines in vitro. The uPA autostimulation was decreased by
blocking the uPA-binding domain of urokinase receptor with antibodies. Regr
ession analysis of zymographic and Western blot data of tumor tissue lysate
s revealed no significant coherency between PCNA and uPA expression. Immuno
histochemical stainings frequently showed different sublocalization of uPA
and PCNA within tumors.
Conclusion: In vitro uPA-mediated growth stimulation is not necessarily tra
nsferable to the in situ situation.